New algorithm enhances deep brain stimulation for Parkinson’s by targeting specific symptoms

FHS
June 8, 2024
11:39 am

Researchers from Mass General Brigham identified therapeutic targets that may optimize symptom-specific treatment for Parkinson’s disease.

Filament Health Announces signing of definitive agreement for convertible note financing, closing of $900,000 non-brokered private placement financing | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, is pleased to announce that, further to

December 6, 2023

New Alzheimer’s disease medication approved in Japan – Pharmaceutical Technology

Japan is the second country to gain approval after the US gained traditional approval for the drug in July 2023. Credit: Ralf Liebhold via www.shutterstock.com.

September 25, 2023

Opinion | An Open Letter to the Next Administration Regarding Primary Care

Martin is executive vice president and CEO of the American Academy of Family Physicians. As we prepare for a new administration and a new Congress,

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.